AXXZIA Inc. (TYO:4936)
342.00
+9.00 (2.70%)
Mar 27, 2026, 3:30 PM JST
AXXZIA Revenue
AXXZIA had revenue of 3.14B JPY in the quarter ending January 31, 2026, a decrease of -2.02%. This brings the company's revenue in the last twelve months to 13.97B, up 7.03% year-over-year. In the fiscal year ending July 31, 2025, AXXZIA had annual revenue of 13.48B with 10.55% growth.
Revenue (ttm)
13.97B
Revenue Growth
+7.03%
P/S Ratio
0.56
Revenue / Employee
56.31M
Employees
248
Market Cap
7.80B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Jul 31, 2025 | 13.48B | 1.29B | 10.55% |
| Jul 31, 2024 | 12.19B | 851.00M | 7.50% |
| Jul 31, 2023 | 11.34B | 3.13B | 38.05% |
| Jul 31, 2022 | 8.22B | 2.43B | 41.96% |
| Jul 31, 2021 | 5.79B | 1.50B | 34.90% |
| Jul 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jul 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jul 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jul 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jul 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Niitaka | 24.16B |
| SHOBIDO | 22.73B |
| Premier Anti-Aging | 14.97B |
| Axas Holdings | 12.45B |
| HABA Laboratories,Inc. | 12.17B |
| Kitanotatsujin | 10.60B |
| Almado | 10.18B |
| Liberta | 10.03B |